Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • johnf50@rocketmail.com johnf50 Mar 12, 2013 6:10 PM Flag

    Barclays conference take away.

    Mostly old news - key components are as follows:

    Vertex has ongoing conversations with potential partners for VX-509 and expects 'data' second half of this year. They already have the data - so my take is that they are planning on having a partnership deal signed by the second half of this year. This is great.

    The consensus of the voting outcomes for the presentation had the following determinations:

    (1) Consensus on Incivek revenue this year is 650 million.

    (2) 74% of the audience believes that the VX-661 data will be positive.

    (3) 60% of the audience believes that the VX-809 data will be positive.

    GLTA - JF

    Sentiment: Strong Buy

 
VRTX
125.08+0.03(+0.02%)May 22 4:00 PMEDT